RESUMEN
A series of nitro substituted benzamide derivatives were synthesized and evaluated for their potential anti-inflammatory activities in vitro. Firstly, all compounds (1-6) were screened for their inhibitory capacity on LPS induced nitric oxide (NO) production in RAW264.7 macrophages. Compounds 5 and 6 demonstrated significantly high inhibition capacities in a dose-dependent manner with IC50 values of 3.7 and 5.3µM, respectively. These two compounds were also accompanied by no cytotoxicity at the studied concentrations (max 50µM) in macrophages. Molecular docking analysis on iNOS revealed that compounds 5 and 6 bind to the enzyme more efficiently compared to other compounds due to having optimum number of nitro groups, orientations and polarizabilities. In addition, 5 and 6 demonstrated distinct regulatory mechanisms for the expression of the iNOS enzyme at the mRNA and protein levels. Specifically, both suppressed expressions of COX-2, IL-1ß and TNF-α significantly, at 10 and 20µM. However, only compound 6 significantly and considerably decreased LPS-induced secretion of IL-1ß and TNF-α. These results suggest that compound 6 may be a multi-potent promising lead compound for further optimization in structure and as well as for in vivo validation studies.
Asunto(s)
Antiinflamatorios/uso terapéutico , Benzamidas/farmacología , Macrófagos/efectos de los fármacos , Óxido Nítrico Sintasa de Tipo II/metabolismo , Nitrocompuestos/farmacología , Animales , Benzamidas/química , Supervivencia Celular , Ciclooxigenasa 2/metabolismo , Interleucina-1beta/metabolismo , Lipopolisacáridos/inmunología , Macrófagos/fisiología , Ratones , Óxido Nítrico/metabolismo , Óxido Nítrico Sintasa de Tipo II/química , Nitrocompuestos/química , Unión Proteica , Células RAW 264.7 , Factor de Necrosis Tumoral alfa/metabolismoRESUMEN
In this study, we aimed to investigate the extent of genotoxic risk and the association between null GSTM1/GSTT1 and GSTP1 Ile105Val variants and cellular DNA damage, as measured by micronucleus (MN) assay in a group of agricultural workers from Denizli, Turkey. Peripheral blood samples were collected from 116 subjects, including 58 workers who were occupationally exposed to pesticides and 58 healthy unexposed controls. The MN frequencies of each individual were assessed by cytokinesis-blocked micronuclei assays on lymphocytes. Genotypes for different GST variants were determined using polymerase chain reaction-based methods. A significant 3.4-fold increase in MN frequency was observed in workers compared with the controls (p < 0.001). Among the GST genotypes, only the GSTM1 null genotype was found to be significantly associated with an increased MN frequency in workers (p = 0.01). Individuals with a concomitant null GSTM1/GSTT1 genotype demonstrated a significant (p = 0.01) increase in MN frequency compared with those with functional isozymes in the exposed worker group. The association of the GSTM1 null genotype with higher MN frequency suggests that it may be a modifier of genotoxic risk in individuals exposed to pesticides and may thus be a candidate susceptibility biomarker for human biomonitoring studies.
Asunto(s)
Agricultores , Glutatión Transferasa/genética , Pruebas de Micronúcleos , Exposición Profesional/efectos adversos , Plaguicidas/toxicidad , Adulto , Estudios de Casos y Controles , Daño del ADN , Monitoreo del Ambiente , Femenino , Frecuencia de los Genes , Marcadores Genéticos , Genotipo , Técnicas de Genotipaje , Gutatión-S-Transferasa pi/genética , Humanos , Linfocitos/efectos de los fármacos , Linfocitos/metabolismo , Masculino , Plaguicidas/sangre , Turquía , Adulto JovenRESUMEN
Spirulina platensis (SP) has been considered as potential food source of 21st century due to its remarkable nutrient profile and therapeutic benefits. However, the cytochrome P450 (CYP)-mediated drug/chemical interaction potential of SP has not yet been pursued. We investigated the effects of SP on the expressions and enzymatic activities of main CYP isozymes. After the rats were orally administered with SP daily for 5 consecutive weeks, there were significant downregulations in hepatic expression levels and inhibition in enzymatic activities of CYP1A2 and CYP2E1 compared to controls. In addition, a significant decrease was observed in CYP2C6-associated enzyme activity with no remarkable changes in messenger RNA (mRNA)/protein levels. The SP application resulted in significant increases in mRNA/protein levels of both CYP2B1 and CYP3A1 without a significant change in enzyme activities. These findings partly explain the chemopreventive properties of SP toward various organ toxicities, mutagenesis, and carcinogenesis; however, its coadministration with some CYP substrates may lead to undesirable drug interactions.